Intention to use long-acting PrEP among MSM in Europe – results from the PROTECT survey from Spain, Italy, Germany, ​France and the United Kingdom

AUTHORS

K. Jonas¹, J. Kolstee¹, H. Wang¹, A. Adriaque Lozano¹, J.C. Croce¹, M. Schroeder², A. Appiah², C. Brown³, A. Milinkovic⁴, J. Scherzer⁵, H. Zimmermann¹


INSTITUTIONS

¹Maastricht University, Maastricht, Netherlands, the, ²ViiV Healthcare Ltd, Brentford, United Kingdom, ³ViiV Healthcare Ltd, Durham, United States, ⁴ViiV Healthcare Ltd & Chelsea and Westminster Hospital, Brentford/London, United Kingdom, ⁵ViiV Healthcare Ltd, München, Germany